Skip to main content

Why Guggenheim Securities initiated NuScale coverage with a ‘buy’ rating

With stock at $13, it sets an $18 target.
Data & News supplied by
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.